Europe L-Carnitine Market Industry Analysis, Size, Share, Future Growth, Trends and Forecast 2020-2027

L-Carnitine is a naturally occurring compound in human and animal bodies; it plays an important role of shuttling fatty acids to and fro in the cells to produce energy. It is produced in the liver and kidneys. However, certain individuals are unable to produce or synthesize required amount of L-Carnitine owing to genetic conditions or defects. Such individuals suffer from primary and secondary L-Carnitine deficiency. The US Food and Drug Administration (FDA) has approved the use of oral and intravenous (IV) L-Carnitine for treating primary and secondary Carnitine deficiency.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @: https://bit.ly/3dmBDYR

Key Players:

• ChengDaPharmaCeuticalsCo., Ltd
• Maxsun Industries Incorporated
• ALPSURE LIFESCIENCES PVT. LTD
• Lonza Group Ltd
• Northeast Pharmaceutical Group Co., Ltd
• MERCK KGaA
• Biosint S.p.A.

L-Carnitine is today commercially advertised as nutritional supplements to enhance exercise performance and promote weight loss. It is also approved to treat Carnitine deficiencies in patients at the end stage of renal diseases, undergoing hemodialysis.. Besides its uses in human nutrition, L-Carnitine is also used as an additive in animal feed formulations. It is used in the poultry industry to increase egg production and improve egg hatchability.

The L-Carnitine market, based on product, is segmented into food grade, pharmaceutical grade, and feed grade. In 2018, the food grade segment accounted for the largest share of the Europe L-Carnitine market, whereas the pharmaceutical grade segment is expected to register the fastest CAGR during the forecast period. L-Carnitine mainly carries out two functions?the first is the transportation of fatty acids into mitochondria, where they are burned and oxidized to produce energy, and the rest is the transportation of waste and toxic compounds out of mitochondria, thus preventing unwanted substances getting accumulated in the body. The consumption of L-Carnitine assists in the treatment of heart conditions such as heart failure or heart attack, angina, and diabetic neuropathy. Besides this, L-Carnitine acts as an antioxidant that rules out harmful free radicals from body, which otherwise can lead to severe cell damage.

Impact of COVID-19 Pandemic on L-Carnitine Market

The recent COVID-19 outbreak began in Wuhan (China) in December 2019, and since then it has spread across the globe at a fast pace. China, Italy, Iran, Spain, the Republic of Korea, France, Germany, and the US are among the worst affected countries in terms confirmed cases and reported deaths as of March 2020. The COVID-19 outbreak has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The overall dip in the global market due to COVID-19 is also affecting the growth of the L-Carnitine market due to factory shutdowns, supply chain discontinuation, and economic downturns.

To inquire about the discount available on this Report, visit @: https://bit.ly/36JUdbS

Competitive scenario:

The study assesses factors such as segmentation, description, and applications of Europe L-Carnitine industries. It derives accurate insights to give a holistic view of the dynamic features of the business, including shares, profit generation, thereby directing focus on the critical aspects of the business.

Sameer Joshi
Call: US: +1-646-491-9876, Apac: +912067274191
Email: sales@premiummarketinsights.com

About Premium market insights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.